Trevena (TRVN): JMP Securities Continues to See AdComm Vote in Favor of Oliceridine

October 10, 2018 9:40 AM

JMP Securities analyst Jason Butler reiterated a Market Outperform rating and $15 price target on Trevena (NASDAQ: TRVN) saying they ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found